ribavirin has been researched along with Depressive Disorder, Major in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (42.31) | 29.6817 |
| 2010's | 13 (50.00) | 24.3611 |
| 2020's | 2 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Bugajska, J; Inglot, M; Janocha-Litwin, J; Malyszczak, K; Marciniak, D; Pawlak, D; Pawlowski, T; Zalewska, M | 1 |
| Baumert, TF; Berg, T; Brants, L; Buggisch, P; Discher, T; Friebe, A; Fromm, G; Kemper, J; Lieb, K; Link, R; Ockenga, J; Reimer, J; Rentrop, M; Sarkar, R; Sarkar, S; Schaefer, M; Schläpfer, T; Spengler, U; Weidenbach, H; Zeuzem, S | 1 |
| Fialho, R; Harrison, N; Pereira, M; Rusted, J; Whale, R | 1 |
| Frydecka, D; Hadryś, T; Inglot, M; Małyszczak, K; Pawłowski, T | 1 |
| Avasthi, A; Chawla, YK; Grover, S; Mahajan, S | 1 |
| Cozzolongo, R; Giannuzzi, V; Lanzilotta, E; Leandro, G; Porcelli, P | 1 |
| Burridge, A; Fialho, R; File, A; Keller, M; Pereira, M; Tibble, J; Whale, R | 1 |
| Eccles, J; Fialho, R; File, A; Haq, I; Keller, M; Pereira, M; Rolt, M; Tibble, J; Whale, R | 1 |
| A, Y; E, F; GM, Sel-D; H, AG; M, A; MM, B; MM, el-S; U, Y | 1 |
| Batista-Neves, S; de Oliveira, IR; Galvão-de Almeida, A; Guindalini, C; Lyra, AC; Miranda-Scippa, A; Paraná, R; Quarantini, LC | 1 |
| Kenis, G; Koek, GH; Prickaerts, J; Robaeys, G; Steinbusch, HW; van Os, J; Wichers, M | 1 |
| Bech, P; Buhl, MR; Färkkilä, M; Hellstrand, K; Hjerrild, S; Lagging, M; Langeland, N; Leutscher, PD; Mørch, K; Norkrans, G; Pedersen, C | 1 |
| Ardèvol, M; Castellví, P; Costa, J; Diago, M; Diez-Quevedo, C; Giménez, D; Giner, P; Martín-Santos, R; Masnou, H; Morillas, RM; Navinés, R; Planas, R; Pretel, J; Solà, R | 1 |
| Barton, D; Dore, G; Kronborg, I; Sasadeusz, JJ; Weltman, M; Yoshihara, M | 1 |
| Rifai, MA; Sabouni, MA | 1 |
| Berg, T; Garkisch, AS; Heinz, A; Hinzpeter, A; Pich, M; Schaefer, M; Schwaiger, M; Uebelhack, R; van Boemmel, F | 1 |
| Hauser, P; Loftis, JM; Rifai, MA | 1 |
| Balderson, K; Sockalingam, S | 1 |
| Asnis, GM; De La Garza, R | 1 |
| Bernard, PH; Castera, L; Champbenoit, P; Constant, A; Couzigou, P; De Ledinghen, V; Demotes-Mainard, J; Henry, C | 1 |
| Hauser, P; Indest, DW; Loftis, JM; Moles, JK; Morasco, BJ; Rifai, MA | 1 |
| Amore, M; Baldini, A; Beverini, E; Bonino, F; Brunetto, M; Carlini, M; Del Debbio, A; Dell'Osso, L; Ferrari, G; Maggi, L; Maj, M; Manca, E; Pini, S; Rucci, P; Scarallo, V; Semeraro, Q | 1 |
| Aszalós, Z; Lengyel, G; Tulassay, Z | 1 |
| Asnis, GM; Borisov, AS; Bruno, CJ; Demetrashvili, MF; Evans, DL; Henderson, MA; Miller, AH; Raison, CL; Reinus, JF; Staab, JP; Weinreib, R; Woolwine, BJ; Zajecka, JM | 1 |
| Batista-Neves, S; Bressan, RA; Galvão, A; Miranda-Scippa, A; Paraná, R; Quarantini, LC | 1 |
| Saunders, JC | 1 |
4 review(s) available for ribavirin and Depressive Disorder, Major
| Article | Year |
|---|---|
Utilizing genomic polymorphisms to personalize hepatitis C therapies.
Topics: Antiviral Agents; Depressive Disorder, Major; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Pharmacogenetics; Polymorphism, Genetic; Ribavirin; Treatment Outcome; Viral Load | 2012 |
Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches.
Topics: Anemia; Antiviral Agents; Depressive Disorder, Major; Hepatitis C, Chronic; Humans; Intercellular Adhesion Molecule-1; Interferon alpha-2; Interferon Type I; Interferon-alpha; Nitric Oxide; Paroxetine; Peptide Hydrolases; Polyethylene Glycols; Prevalence; Recombinant Proteins; Ribavirin; Risk Factors; Selective Serotonin Reuptake Inhibitors; Thyroid Diseases | 2006 |
[Hepatitis C viral infection and depression].
Topics: Antidepressive Agents; Antiviral Agents; Depressive Disorder, Major; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin | 2007 |
Neuropsychiatric symptoms of hepatitis C.
Topics: Antiviral Agents; Anxiety Disorders; Brain; Chronic Disease; Cognition Disorders; Depressive Disorder, Major; Hepatitis C; Humans; Neuropsychological Tests; Ribavirin | 2008 |
10 trial(s) available for ribavirin and Depressive Disorder, Major
| Article | Year |
|---|---|
The role of alexithymia in quality of life impairment in patients with chronic hepatitis C during antiviral treatment.
Topics: Affective Symptoms; Antiviral Agents; Depressive Disorder, Major; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Mood Disorders; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin; Stress, Psychological | 2015 |
Major depressive disorder and generalized anxiety disorder and response to treatment in hepatitis C patients in Egypt.
Topics: Adult; Antiviral Agents; Anxiety Disorders; Depressive Disorder, Major; Egypt; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prevalence; Recombinant Proteins; Ribavirin; Treatment Outcome; Young Adult | 2015 |
Depressive symptoms following interferon-α therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor?
Topics: Antiviral Agents; Brain-Derived Neurotrophic Factor; Cytokines; Depression; Depressive Disorder, Major; Female; Hepatitis C, Chronic; Humans; Hydrocortisone; Immunologic Factors; Interferon-alpha; Male; Psychiatric Status Rating Scales; Ribavirin; Time Factors | 2011 |
Prophylactic treatment with escitalopram of pegylated interferon alfa-2a-induced depression in hepatitis C: a 12-week, randomized, double-blind, placebo-controlled trial.
Topics: Adult; Antiviral Agents; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Psychiatric Status Rating Scales; Recombinant Proteins; Ribavirin; Treatment Outcome | 2011 |
Clinical experience with the treatment of hepatitis C infection in patients on opioid pharmacotherapy.
Topics: Adult; Analgesics, Opioid; Antiviral Agents; Australia; Depressive Disorder, Major; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Medication Adherence; Opiate Substitution Treatment; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Substance Abuse Detection; Substance Abuse, Intravenous; Treatment Outcome | 2011 |
Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C.
Topics: Adult; Antidepressive Agents, Second-Generation; Antiviral Agents; Citalopram; Depressive Disorder, Major; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Patient Dropouts; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Risk Factors | 2005 |
A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C.
Topics: Adult; Antidepressive Agents, Second-Generation; Antiviral Agents; Depressive Disorder, Major; Drug Therapy, Combination; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Paroxetine; Personality Inventory; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Veterans | 2007 |
Subthreshold mania as predictor of depression during interferon treatment in HCV+ patients without current or lifetime psychiatric disorders.
Topics: Administration, Oral; Adult; Aged; Antiviral Agents; Bipolar Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Pilot Projects; Recombinant Proteins; Ribavirin; Risk Factors; Statistics as Topic | 2007 |
Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Depressive Disorder, Major; Double-Blind Method; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Paroxetine; Ribavirin | 2007 |
Incidence of psychiatric side effects during pegylated interferon- alpha retreatment in nonresponder hepatitis C virus-infected patients.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Antiviral Agents; Depressive Disorder, Major; Drug Therapy, Combination; Female; Hepatitis C; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Panic Disorder; Polyethylene Glycols; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Recombinant Proteins; Ribavirin; Risk Assessment; Risk Factors; Time Factors; Treatment Failure | 2007 |
12 other study(ies) available for ribavirin and Depressive Disorder, Major
| Article | Year |
|---|---|
The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-α2a and oral ribavirin.
Topics: Adult; Antiviral Agents; Cross-Sectional Studies; Depression; Depressive Disorder, Major; Female; Hepatitis C, Chronic; Humans; Immunologic Factors; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-alpha; Kynurenic Acid; Kynurenine; Longitudinal Studies; Male; Middle Aged; ortho-Aminobenzoates; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tryptophan | 2021 |
Influence of gender on cytokine induced depression and treatment: Gender aspects of IFN-α-induced depression.
Topics: Antiviral Agents; Cytokines; Depression; Depressive Disorder, Major; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Ribavirin | 2021 |
Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C.
Topics: Adult; Antiviral Agents; Coinfection; Depressive Disorder, Major; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Prospective Studies; Ribavirin | 2017 |
Biological and psychological components of depression in patients receiving IFN-alpha therapy for hepatitis C.
Topics: Antiviral Agents; Depression; Depressive Disorder, Major; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Prospective Studies; Psychiatric Status Rating Scales; Ribavirin | 2019 |
Role of baseline depressive symptoms in the development of depressive episode in patients receiving antiviral therapy for hepatitis C infection.
Topics: Adult; Antiviral Agents; Depression; Depressive Disorder, Major; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Incidence; Interferon-alpha; Male; Middle Aged; Personality Inventory; Polyethylene Glycols; Prospective Studies; Psychiatric Status Rating Scales; Recombinant Proteins; Ribavirin; Severity of Illness Index | 2014 |
Norepinephrine-enhancing antidepressant exposure associated with reduced antiviral effect of interferon alpha on hepatitis C.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antiviral Agents; Cohort Studies; Depressive Disorder, Major; Drug Interactions; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Norepinephrine; Prospective Studies; Ribavirin; Selective Serotonin Reuptake Inhibitors; Young Adult | 2016 |
Psychomotor retardation and vulnerability to interferon alpha induced major depressive disorder: Prospective study of a chronic hepatitis C cohort.
Topics: Adult; Aged; Antidepressive Agents; Antiviral Agents; Depression; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Psychomotor Performance; Ribavirin | 2015 |
Is the interferon-α-triggered depressive episode a self-limited kind of depression? Four cases of persistent affective symptoms after antiviral treatment in HCV-infected individuals.
Topics: Antiviral Agents; Depressive Disorder, Major; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Hospitals, University; Humans; Interferon alpha-2; Interferon-alpha; Long-Term Care; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; Risk Factors; Substance Withdrawal Syndrome | 2010 |
Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C.
Topics: Adult; Antiviral Agents; Depressive Disorder, Major; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Treatment Failure | 2010 |
The association between viral clearance and depression in patients with hepatitis C receiving interferon-alpha and ribavirin.
Topics: Comorbidity; Depressive Disorder, Major; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin; Treatment Failure; Treatment Outcome; Viral Load | 2005 |
Major depressive episode with psychotic features induced by pegylated interferon-alpha-2b and ribavirin treatment.
Topics: Adult; Antiviral Agents; Depressive Disorder, Major; Drug Therapy, Combination; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Psychoses, Substance-Induced; Recombinant Proteins; Ribavirin | 2005 |
Impact on adherence and sustained virological response of psychiatric side effects during peginterferon and ribavirin therapy for chronic hepatitis C.
Topics: Antiviral Agents; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Mood Disorders; Patient Compliance; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Risk Factors; Treatment Failure | 2006 |